Published in J Bacteriol on March 01, 1993
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev (1996) 13.91
Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factors. J Bacteriol (1994) 3.15
Regulation of the alginate biosynthesis gene algC in Pseudomonas aeruginosa during biofilm development in continuous culture. Appl Environ Microbiol (1995) 3.14
Transposon-derived Brucella abortus rough mutants are attenuated and exhibit reduced intracellular survival. Infect Immun (1998) 2.36
The Pseudomonas aeruginosa algC gene encodes phosphoglucomutase, required for the synthesis of a complete lipopolysaccharide core. J Bacteriol (1994) 2.28
Biosynthesis of the Pseudomonas aeruginosa Extracellular Polysaccharides, Alginate, Pel, and Psl. Front Microbiol (2011) 1.84
Functional equivalence of Escherichia coli sigma E and Pseudomonas aeruginosa AlgU: E. coli rpoE restores mucoidy and reduces sensitivity to reactive oxygen intermediates in algU mutants of P. aeruginosa. J Bacteriol (1995) 1.83
Mutant analysis and cellular localization of the AlgI, AlgJ, and AlgF proteins required for O acetylation of alginate in Pseudomonas aeruginosa. J Bacteriol (2002) 1.55
Identification of rfbA, involved in B-band lipopolysaccharide biosynthesis in Pseudomonas aeruginosa serotype O5. Infect Immun (1995) 1.54
Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity. Int J Med Microbiol (2007) 1.49
In vitro alginate polymerization and the functional role of Alg8 in alginate production by Pseudomonas aeruginosa. Appl Environ Microbiol (2006) 1.47
Deletion of algK in mucoid Pseudomonas aeruginosa blocks alginate polymer formation and results in uronic acid secretion. J Bacteriol (1998) 1.46
Purification and characterization of phosphomannomutase/phosphoglucomutase from Pseudomonas aeruginosa involved in biosynthesis of both alginate and lipopolysaccharide. J Bacteriol (1994) 1.36
Characterization of the serogroup O11 O-antigen locus of Pseudomonas aeruginosa PA103. J Bacteriol (1999) 1.33
Gut microbial gene expression in mother-fed and formula-fed piglets. PLoS One (2010) 1.27
AlgX is a periplasmic protein required for alginate biosynthesis in Pseudomonas aeruginosa. J Bacteriol (2004) 1.18
Microbial alginate production, modification and its applications. Microb Biotechnol (2013) 1.14
Structural basis for alginate secretion across the bacterial outer membrane. Proc Natl Acad Sci U S A (2011) 1.11
Pseudomonas aeruginosa lipopolysaccharide: evidence that the O side chains and common antigens are on the same molecule. J Bacteriol (1993) 1.05
Alginate lyase (AlgL) activity is required for alginate biosynthesis in Pseudomonas aeruginosa. J Bacteriol (2005) 1.04
Isolation and characterization of two genes, waaC (rfaC) and waaF (rfaF), involved in Pseudomonas aeruginosa serotype O5 inner-core biosynthesis. J Bacteriol (1997) 1.02
The exopolysaccharide gene cluster Bcam1330-Bcam1341 is involved in Burkholderia cenocepacia biofilm formation, and its expression is regulated by c-di-GMP and Bcam1349. Microbiologyopen (2012) 0.91
Alteration of the lipopolysaccharide structure affects the functioning of the Xcp secretory system in Pseudomonas aeruginosa. J Bacteriol (2000) 0.89
Genetics of bacterial alginate: alginate genes distribution, organization and biosynthesis in bacteria. Curr Genomics (2007) 0.89
Comparative transcriptome analyses of Pseudomonas aeruginosa. Hum Genomics (2009) 0.87
Pseudomonas aeruginosa Inhibition of Flagellin-activated NF-kappaB and interleukin-8 by human airway epithelial cells. Infect Immun (2009) 0.80
The Pseudomonas aeruginosa AlgZR two-component system coordinates multiple phenotypes. Front Cell Infect Microbiol (2014) 0.77
Characterization of the algC gene expression pattern in the multidrug resistant Acinetobacter baumannii AIIMS 7 and correlation with biofilm development on abiotic surface. ScientificWorldJournal (2014) 0.75
Investigating the link between imipenem resistance and biofilm formation by Pseudomonas aeruginosa. Microb Ecol (2014) 0.75
Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08
A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res (1979) 214.95
New M13 vectors for cloning. Methods Enzymol (1983) 90.74
Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans. Proc Natl Acad Sci U S A (1979) 44.75
Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J Bacteriol (1983) 25.26
A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots. Anal Biochem (1984) 22.53
Construction of a broad host range cosmid cloning vector and its use in the genetic analysis of Rhizobium mutants. Gene (1982) 20.39
Molecular cloning of the plasmid RP4 primase region in a multi-host-range tacP expression vector. Gene (1986) 13.92
Molecular characterization of cloned avirulence genes from race 0 and race 1 of Pseudomonas syringae pv. glycinea. J Bacteriol (1987) 12.50
Resolution of recent evolutionary divergence among Escherichia coli from related lineages: the application of pulsed field electrophoresis to molecular epidemiology. J Infect Dis (1990) 8.33
Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect Immun (1983) 6.24
Cloning of genes controlling alginate biosynthesis from a mucoid cystic fibrosis isolate of Pseudomonas aeruginosa. J Bacteriol (1984) 6.22
Exotoxins of Pseudomonas aeruginosa. I. Factors that influence the production of exotoxin A. J Infect Dis (1973) 5.92
Escherichia-Pseudomonas shuttle vectors derived from pUC18/19. Gene (1991) 5.90
Cloning and expression in Pseudomonas aeruginosa of a gene involved in the production of alginate. J Bacteriol (1984) 4.95
Transformation of Pseudomonas aeruginosa by electroporation. Nucleic Acids Res (1989) 4.75
Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients. Clin Microbiol Rev (1991) 2.87
The relationship of phenotype changes in Pseudomonas aeruginosa to the clinical condition of patients with cystic fibrosis. Am Rev Respir Dis (1983) 2.68
A physical genome map of Pseudomonas aeruginosa PAO. EMBO J (1989) 2.60
Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa. Infect Immun (1984) 2.39
Cloning of genes from mucoid Pseudomonas aeruginosa which control spontaneous conversion to the alginate production phenotype. J Bacteriol (1988) 2.39
Heterogeneity of lipopolysaccharides from Pseudomonas aeruginosa: analysis of lipopolysaccharide chain length. J Bacteriol (1988) 2.35
A mutation in algN permits trans activation of alginate production by algT in Pseudomonas species. J Bacteriol (1993) 2.31
Isolation and characterization of a high-molecular-weight polysaccharide from the slime of Pseudomonas aeruginosa. Infect Immun (1978) 2.22
Characterization and regulation of the Pseudomonas aeruginosa algC gene encoding phosphomannomutase. J Biol Chem (1991) 2.20
The structure of O-specific polysaccharides and serological classification of Pseudomonas aeruginosa (a review). Acta Microbiol Hung (1988) 2.07
A combined physical and genetic map of Pseudomonas aeruginosa PAO. J Gen Microbiol (1990) 2.05
The extraction and analysis of lipopolysaccharides from Pseudomonas aeruginosa strain PAO, and three rough mutants. Can J Microbiol (1979) 2.05
Effect of lipopolysaccharide mutations and temperature on plasmid transformation efficiency in Pseudomonas aeruginosa. Can J Microbiol (1986) 2.03
Lipopolysaccharide and high-molecular-weight polysaccharide serotypes of Pseudomonas aeruginosa. J Infect Dis (1982) 1.86
Construction and characterization of Pseudomonas aeruginosa algB mutants: role of algB in high-level production of alginate. J Bacteriol (1987) 1.75
Mucoid Pseudomonas aeruginosa in cystic fibrosis: signal transduction and histone-like elements in the regulation of bacterial virulence. Mol Microbiol (1991) 1.54
Physical mapping of virulence-associated genes in Pseudomonas aeruginosa by transverse alternating-field electrophoresis. Infect Immun (1991) 1.53
Analysis of a common-antigen lipopolysaccharide from Pseudomonas aeruginosa. J Bacteriol (1989) 1.53
The chemical composition of the lipopolysaccharide from Pseudomonas aeruginosa strain PAO and a spontaneously derived rough mutant. Microbios (1977) 1.47
Passive protection against Pseudomonas aeruginosa infection in an experimental leukopenic mouse model. Infect Immun (1983) 1.45
Cloning and surface expression of Pseudomonas aeruginosa O antigen in Escherichia coli. Proc Natl Acad Sci U S A (1992) 1.43
The impact of two-dimensional pulsed-field gel electrophoresis techniques for the consistent and complete mapping of bacterial genomes: refined physical map of Pseudomonas aeruginosa PAO. Nucleic Acids Res (1991) 1.42
Molecular cloning of genes involved with expression of A-band lipopolysaccharide, an antigenically conserved form, in Pseudomonas aeruginosa. J Bacteriol (1991) 1.35
Polyagglutinability due to loss of O-antigenic determinants in Pseudomonas aeruginosa strains isolated from cystic fibrosis patients. Acta Pathol Microbiol Immunol Scand B (1985) 1.25
Structure of an extracellular cross-reactive polysaccharide from Pseudomonas aeruginosa immunotype 4. J Biol Chem (1988) 1.16
A new common polysaccharide antigen of strains of Pseudomonas aeruginosa detected with a monoclonal antibody. J Infect Dis (1985) 1.15
Pseudomonas aeruginosa bacteriophage phi PLS27-lipopolysaccharide interactions. J Virol (1981) 1.06
Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis. Lancet (1991) 1.02
Characterization of the human immune response to a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine. J Lab Clin Med (1988) 0.94
The structure and serologic distribution of an extracellular neutral polysaccharide from Pseudomonas aeruginosa immunotype 3. J Biol Chem (1989) 0.93
Occurrence of D-rhamnan as the common antigen reactive against monoclonal antibody E87 in Pseudomonas aeruginosa IFO 3080 and other strains. J Bacteriol (1990) 0.90
A partial modification of the carbazole method of Bitter and Muir for quantitation of hexuronic acids. Anal Biochem (1979) 0.84
Determination of genome size of Pseudomonas aeruginosa by PFGE: analysis of restriction fragments. Nucleic Acids Res (1990) 0.81
Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect (2000) 7.50
Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect Immun (1983) 6.24
Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science (1999) 4.08
Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction. J Infect Dis (1985) 3.61
The ica locus of Staphylococcus epidermidis encodes production of the capsular polysaccharide/adhesin. Infect Immun (1998) 3.44
Isolation and characterization of a capsular polysaccharide adhesin from Staphylococcus epidermidis. J Infect Dis (1988) 3.15
Immunological basis of serum resistance of Neisseria gonorrhoeae. J Gen Microbiol (1982) 2.66
Immunochemical characterization of the mucoid exopolysaccharide of Pseudomonas aeruginosa. J Infect Dis (1983) 2.59
Role of Pseudomonas aeruginosa mucoid exopolysaccharide in adherence to tracheal cells. Infect Immun (1985) 2.54
Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread. Infect Immun (2000) 2.41
Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa. Infect Immun (1996) 2.40
Induction of human interleukin-1 by toxic-shock-syndrome toxin-1. J Infect Dis (1985) 2.37
Pseudomonas aeruginosa invades corneal epithelial cells during experimental infection. Infect Immun (1994) 2.37
The human amygdala plays an important role in gaze monitoring. A PET study. Brain (1999) 2.33
A mutation in algN permits trans activation of alginate production by algT in Pseudomonas species. J Bacteriol (1993) 2.31
Pseudomonas aeruginosa invasion of and multiplication within corneal epithelial cells in vitro. Infect Immun (1995) 2.27
Virulence studies, in mice, of transposon-induced mutants of Staphylococcus aureus differing in capsule size. J Infect Dis (1987) 2.23
Isolation and characterization of a high-molecular-weight polysaccharide from the slime of Pseudomonas aeruginosa. Infect Immun (1978) 2.22
Rapid and sensitive method for evaluating Pseudomonas aeruginosa virulence factors during corneal infections in mice. Infect Immun (1995) 2.17
A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1. Infect Immun (1987) 2.13
Contribution of proteases and LasR to the virulence of Pseudomonas aeruginosa during corneal infections. Infect Immun (1997) 2.11
Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa. Infect Immun (1978) 2.04
Pathogenesis of infections related to intravascular catheterization. Clin Microbiol Rev (1993) 2.02
Isolation and characterization of transposon mutants of Staphylococcus epidermidis deficient in capsular polysaccharide/adhesin and slime. Infect Immun (1993) 1.99
Safety and immunogenicity of high molecular weight polysaccharide vaccine from immunotype 1 Pseudomonas aeruginosa. J Clin Invest (1982) 1.97
[Therapeutic efficacy of postoperative irradiation on carcinoma of the breast]. Nihon Gan Chiryo Gakkai Shi (1990) 1.92
Pseudomonas aeruginosa adhesins for tracheobronchial mucin. Infect Immun (1987) 1.87
Lipopolysaccharide and high-molecular-weight polysaccharide serotypes of Pseudomonas aeruginosa. J Infect Dis (1982) 1.86
Polysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patients. J Clin Microbiol (1986) 1.76
Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence. Nature (2001) 1.66
Extended contact lens wear enhances Pseudomonas aeruginosa adherence to human corneal epithelium. Invest Ophthalmol Vis Sci (1992) 1.60
Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis. N Engl J Med (1987) 1.59
Transposon mutants of Staphylococcus epidermidis deficient in elaboration of capsular polysaccharide/adhesin and slime are avirulent in a rabbit model of endocarditis. J Infect Dis (1994) 1.59
Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Infect Immun (1999) 1.57
Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype. Infect Immun (1999) 1.54
Modulation of Pseudomonas aeruginosa adherence to the corneal surface by mucus. Infect Immun (1994) 1.52
Induction of interleukin-1 by strains of Staphylococcus aureus from patients with nonmenstrual toxic shock syndrome. J Infect Dis (1986) 1.52
Functional delineation of the human occipito-temporal areas related to face and scene processing. A PET study. Brain (2000) 1.52
Characterization of dihydropyrimidine dehydrogenase on immunohistochemistry in colon carcinoma, and correlation between immunohistochemical score and protein level or messenger RNA expression. Ann Oncol (2000) 1.50
Union of the genera Microbacterium Orla-Jensen and Aureobacterium Collins et al. in a redefined genus Microbacterium. Int J Syst Bacteriol (1998) 1.50
Opsonophagocytic killing activity of rabbit antibody to Pseudomonas aeruginosa mucoid exopolysaccharide. Infect Immun (1985) 1.48
Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of pulmonary aspergillosis. Antimicrob Agents Chemother (2000) 1.48
Hyperlipidaemia is positively correlated with lymph node metastasis in men with early gastric cancer. Br J Surg (2004) 1.47
High-molecular-weight polysaccharide antigen from Pseudomonas aeruginosa immunotype 2. Infect Immun (1981) 1.47
Correlation of the biologic responses of C3H/HEJ mice to endotoxin with the chemical and structural properties of the lipopolysaccharides from Pseudomonas aeruginosa and Escherichia coli. J Immunol (1981) 1.44
Cytochrome P-450 55A1 (P-450dNIR) acts as nitric oxide reductase employing NADH as the direct electron donor. J Biol Chem (1993) 1.44
Cloning and surface expression of Pseudomonas aeruginosa O antigen in Escherichia coli. Proc Natl Acad Sci U S A (1992) 1.43
Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract. J Immunol (2001) 1.43
Competitive, enzyme-linked immunosorbent assay for toxic shock syndrome toxin 1. J Clin Microbiol (1985) 1.41
Antibody to the capsular polysaccharide/adhesin protects rabbits against catheter-related bacteremia due to coagulase-negative staphylococci. J Infect Dis (1990) 1.41
Induction of telomerase activity in fibroblasts from bleomycin-injured lungs. Am J Respir Cell Mol Biol (2000) 1.39
Proposal of six new species in the genus Microbacterium and transfer of Flavobacterium marinotypicum ZoBell and Upham to the genus Microbacterium as Microbacterium maritypicum comb. nov. Int J Syst Bacteriol (1998) 1.39
Endemic nosocomial transmission of Staphylococcus epidermidis bacteremia isolates in a neonatal intensive care unit over 10 years. J Infect Dis (1994) 1.38
Neural substrates for recognition of familiar voices: a PET study. Neuropsychologia (2001) 1.38
Mucoid Escherichia coli in cystic fibrosis. N Engl J Med (1981) 1.37
Occurrence of capsular polysaccharide/adhesin among clinical isolates of coagulase-negative staphylococci. J Infect Dis (1993) 1.37
Polyclonal and monoclonal antibody therapy for experimental Pseudomonas aeruginosa pneumonia. Infect Immun (1986) 1.37
Safety and immunogenicity of group Y and group W135 meningococcal capsular polysaccharide vaccines in adults. Infect Immun (1981) 1.37
Protection against endocarditis due to Staphylococcus epidermidis by immunization with capsular polysaccharide/adhesin. Circulation (1991) 1.36
Lipopolysaccharide outer core is a ligand for corneal cell binding and ingestion of Pseudomonas aeruginosa. Invest Ophthalmol Vis Sci (1996) 1.36
Cystic fibrosis transmembrane conductance regulator-mediated corneal epithelial cell ingestion of Pseudomonas aeruginosa is a key component in the pathogenesis of experimental murine keratitis. Infect Immun (1999) 1.36
Cross-protection by Pseudomonas aeruginosa polysaccharides. Infect Immun (1982) 1.34
Phylogenetic study of the species within the family Streptomycetaceae. Antonie Van Leeuwenhoek (2011) 1.34
Characterization of the serogroup O11 O-antigen locus of Pseudomonas aeruginosa PA103. J Bacteriol (1999) 1.33
Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer. Br J Cancer (2000) 1.31
Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci. Infect Immun (2000) 1.29
Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinoma. Lung Cancer (2013) 1.27
Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522. Br J Cancer (1999) 1.25
Characterization of the human immune response to a polysaccharide vaccine from Pseudomonas aeruginosa. J Infect Dis (1983) 1.25
Functionally active monoclonal antibody that recognizes an epitope on the O side chain of Pseudomonas aeruginosa immunotype-1 lipopolysaccharide. Infect Immun (1986) 1.23
Activation of the right inferior frontal cortex during assessment of facial emotion. J Neurophysiol (1999) 1.23
Chemical characterization and immunogenicity of capsular polysaccharide isolated from mucoid Staphylococcus aureus. Infect Immun (1987) 1.22
Vocal identification of speaker and emotion activates different brain regions. Neuroreport (1997) 1.16
Structure of an extracellular cross-reactive polysaccharide from Pseudomonas aeruginosa immunotype 4. J Biol Chem (1988) 1.16
Induction in mice of cell-mediated immunity to Pseudomonas aeruginosa by high molecular weight polysaccharide and vinblastine. J Immunol (1982) 1.16
The rfb locus from Pseudomonas aeruginosa strain PA103 promotes the expression of O antigen by both LPS-rough and LPS-smooth isolates from cystic fibrosis patients. Mol Microbiol (1994) 1.13
Blood proteins do not promote adherence of coagulase-negative staphylococci to biomaterials. Infect Immun (1991) 1.12
Syndecan-1 shedding is enhanced by LasA, a secreted virulence factor of Pseudomonas aeruginosa. J Biol Chem (2000) 1.12
Suppression of lymphocyte and neutrophil functions by Pseudomonas aeruginosa mucoid exopolysaccharide (alginate): reversal by physicochemical, alginase, and specific monoclonal antibody treatments. Infect Immun (1993) 1.11
Psoas abscess complicating Crohn's disease: report of a case. Surg Today (2000) 1.11
Toxoid of Pseudomonas aeruginosa exotoxin A generated by deletion of an active-site residue. Infect Immun (1988) 1.10
Mediation of the killing of rough, mucoid isolates of Pseudomonas aeruginosa from patients with cystic fibrosis by the alternative pathway of complement. J Infect Dis (1984) 1.09
In vitro T cell-mediated killing of Pseudomonas aeruginosa. I. Evidence that a lymphokine mediates killing. J Immunol (1984) 1.09
Purified capsular polysaccharide-induced immunity to Staphylococcus aureus infection. J Infect Dis (1988) 1.09
The pathogenic role of Staphylococcus epidermidis capsular polysaccharide/adhesin in a low-inoculum rabbit model of prosthetic valve endocarditis. Circulation (1995) 1.08
The role of the CFTR in susceptibility to Pseudomonas aeruginosa infections in cystic fibrosis. Trends Microbiol (2000) 1.08
Activation reduction in anterior temporal cortices during repeated recognition of faces of personal acquaintances. Neuroimage (2001) 1.07
An immunohistological evaluation of Pseudomonas aeruginosa pulmonary infection in two patients with cystic fibrosis. Pediatr Res (1987) 1.07
Immunogenic and antigenic properties of a heptavalent high-molecular-weight O-polysaccharide vaccine derived from Pseudomonas aeruginosa. Infect Immun (1994) 1.06
Pseudomonas aeruginosa lipopolysaccharide: evidence that the O side chains and common antigens are on the same molecule. J Bacteriol (1993) 1.05
In vitro T cell-mediated killing of Pseudomonas aeruginosa. II. The role of macrophages and T cell subsets in T cell killing. J Immunol (1985) 1.05
Vaccine potential of poly-1-6 beta-D-N-succinylglucosamine, an immunoprotective surface polysaccharide of Staphylococcus aureus and Staphylococcus epidermidis. J Biotechnol (2000) 1.05
The role of cytophilic IgG3 antibody in T cell-mediated resistance to infection with the extracellular bacterium, Pseudomonas aeruginosa. J Immunol (1991) 1.05
Polyclonal B cell stimulation and interleukin 1 induction by the mucoid exopolysaccharide of Pseudomonas aeruginosa associated with cystic fibrosis. J Immunol (1985) 1.03
Immunogenic properties of Pseudomonas aeruginosa mucoid exopolysaccharide. Infect Immun (1990) 1.03
Relation between thymidylate synthase expression and survival in colon carcinoma, and determination of appropriate application of 5-fluorouracil by immunohistochemical method. Ann Surg Oncol (2000) 1.03
Structural analysis of the lipopolysaccharide core of a rough, cystic fibrosis isolate of Pseudomonas aeruginosa. Eur J Biochem (2001) 1.02